Med bibl SkaS

Liquid biopsies in solid tumors
Komihåglistan är tom
Vis
Titel och upphov
  • Liquid biopsies in solid tumors
Utgivning, distribution etc.
  • Cham, Switzerland : Humana Press, 2017.
National Library of Medicine (NLM) klassifikationskod
  • QZ 241
DDC klassifikationskod (Dewey Decimal Classification)
Fysisk beskrivning
  • 1 online resource : illustrations.
Serietitel - ej biuppslagsform
Anmärkning: Bibliografi etc.
  • Includes bibliographical references index.
Anmärkning: Innehåll
  • 1. Blood-based diagnostics in solid tumors: an overview -- 2. Circulating tumor cells (CTCs) in primary disease: the seed for metastasis -- 3. Enumeration and molecular analysis of CTCs in metastatic disease: The breast cancer model -- 4. Epithelial-Mesenchymal Transition (EMT) and cancer stem cells (CSCs): The traveling metastasis -- 5. Detection and monitoring of circulating immune cells in solid tumors: shifting priorities -- 6. Circulating-free tumor DNA (ctDNA): the real-time liquid biopsy -- 7. CTCs and ctDNA: two tales of a complex biology -- 8. Exosome: decoding the messaging system.
Anmärkning: Innehållsbeskrivning, sammanfattning
  • This volume, with chapters written by experts in the field of cancerous tumors, details the key factors associated with liquid biopsies in solid tumors: blood-based diagnostics; circulating tumor cells; enumeration and molecular analysis (association with breast cancer); epithelialmesenchymal transition; detection and monitoring; circulating-free tumor DNA; CTCs and ctDNA; and the exosome. The field of blood-based diagnostics is rapidly evolving demonstrating the possibility of real-time molecular analysis of cancer cells and their phenotype and genotype. Circulating Tumor Cell (CTCs) have demonstrated prognostic and predictive value in advanced cancer and represents a source of tumor cells for transcriptome and genomic analysis. Most recently, the detection of genomic abnormalities in the peripheral blood by sensitive and selective PCR methods (liquid biopsy) opened to the option of a comprehensive blood-based tumor analysis. Similar information can be obtained by analysis of exosome, a natural packaging and messaging system being explored in advanced malignancies. The final frontier is the evaluation of immune cells determinant of innate and adaptive immunity.
Term
Genre/Form
  • Electronic books.
Personnamn
Annat medium
  • Print version: Liquid biopsies in solid tumors. Cham, Switzerland : Humana Press, 2017 ISBN 3319509551 ISBN 9783319509556
Seriebiuppslag under titel
  • Cancer drug discovery and development.
Elektronisk adress och åtkomst (URI)
  • http://link.springer.com/10.1007/978-3-319-50956-3
ISBN
  • 9783319509563
  • 331950956X
*00000000cam a2200000Ii 4500
*00178666
*00520181120084252.6
*006m     o  d
*007cr cnu|||unuuu
*008170329s2017    sz a    ob    001 0 eng d
*015  $aGBB8J4735$2bnb
*0167 $a019091156$2Uk
*019  $a980758761$a981071002$a981149109$a981632542$a981830958$a984852375$a999554581$a1005755191$a1011852524
*020  $a9783319509563$q(electronic bk.)
*020  $a331950956X$q(electronic bk.)
*020  $z9783319509556$q(print)
*020  $z3319509551
*0247 $a10.1007/978-3-319-50956-3$2doi
*029  $aAU@$b000059919421
*029  $aUKMGB$b019091156
*035  $a(OCoLC)979992076$z(OCoLC)980758761$z(OCoLC)981071002$z(OCoLC)981149109$z(OCoLC)981632542$z(OCoLC)981830958$z(OCoLC)984852375$z(OCoLC)999554581$z(OCoLC)1005755191$z(OCoLC)1011852524
*035  $a(OCoLC)ocn979992076
*037  $acom.springer.onix.9783319509563$bSpringer Nature
*040  $aN$beng$erda$epn$cN$dGW5XE$dN$dYDX$dDKU$dCOO$dAZU$dUPM$dOCLCO$dUAB$dOCLCO$dESU$dVT2$dJBG$dIAD$dICW$dICN$dILO$dOTZ$dOCLCQ$dIOG$dOCLCO$dU3W$dOCLCO$dOCLCA$dCAUOI$dOCLCF$dOCLCO$dKSU$dOCLCO$dUKMGB$dOCLCO
*049  $aMAIN
*050 4$aRC255
*060 4$aQZ 241
*072 7$aHEA$x039000$2bisacsh
*072 7$aMED$x014000$2bisacsh
*072 7$aMED$x022000$2bisacsh
*072 7$aMED$x112000$2bisacsh
*072 7$aMED$x045000$2bisacsh
*072 7$aMJCL$2bicssc
*08204$a616.99/40758$223
*24500$aLiquid biopsies in solid tumors /$cMassimo Cristofanilli, editors.
*264 1$aCham, Switzerland :$bHumana Press,$c2017.
*300  $a1 online resource :$billustrations.
*336  $atext$btxt$2rdacontent
*337  $acomputer$bc$2rdamedia
*338  $aonline resource$bcr$2rdacarrier
*347  $atext file$bPDF$2rda
*4901 $aCancer drug discovery and development,$x2196-9906
*504  $aIncludes bibliographical references index.
*5050 $a1. Blood-based diagnostics in solid tumors: an overview -- 2. Circulating tumor cells (CTCs) in primary disease: the seed for metastasis -- 3. Enumeration and molecular analysis of CTCs in metastatic disease: The breast cancer model -- 4. Epithelial-Mesenchymal Transition (EMT) and cancer stem cells (CSCs): The traveling metastasis -- 5. Detection and monitoring of circulating immune cells in solid tumors: shifting priorities -- 6. Circulating-free tumor DNA (ctDNA): the real-time liquid biopsy -- 7. CTCs and ctDNA: two tales of a complex biology -- 8. Exosome: decoding the messaging system.
*520  $aThis volume, with chapters written by experts in the field of cancerous tumors, details the key factors associated with liquid biopsies in solid tumors: blood-based diagnostics; circulating tumor cells; enumeration and molecular analysis (association with breast cancer); epithelialmesenchymal transition; detection and monitoring; circulating-free tumor DNA; CTCs and ctDNA; and the exosome. The field of blood-based diagnostics is rapidly evolving demonstrating the possibility of real-time molecular analysis of cancer cells and their phenotype and genotype. Circulating Tumor Cell (CTCs) have demonstrated prognostic and predictive value in advanced cancer and represents a source of tumor cells for transcriptome and genomic analysis. Most recently, the detection of genomic abnormalities in the peripheral blood by sensitive and selective PCR methods (liquid biopsy) opened to the option of a comprehensive blood-based tumor analysis. Similar information can be obtained by analysis of exosome, a natural packaging and messaging system being explored in advanced malignancies. The final frontier is the evaluation of immune cells determinant of innate and adaptive immunity.
*5880 $aOnline resource; title from PDF title page (SpringerLink, viewed April 4, 2017).
*590  $aSpringerLink$bSpringer Medicine eBooks 2017 English+International
*650 0$aTumors$xDiagnosis.
*650 0$aTumors$xMolecular diagnosis.
*650 7$aHEALTH & FITNESS$xDiseases$xGeneral.$2bisacsh
*650 7$aMEDICAL$xClinical Medicine.$2bisacsh
*650 7$aMEDICAL$xDiseases.$2bisacsh
*650 7$aMEDICAL$xEvidence-Based Medicine.$2bisacsh
*650 7$aMEDICAL$xInternal Medicine.$2bisacsh
*650 7$aTumors$xDiagnosis.$2fast$0(OCoLC)fst01158766
*650 2$aNeoplasms$xdiagnosis.
*650 7$aOncology.$2bicssc
*655 4$aElectronic books.
*7001 $aCristofanilli, Massimo,$eeditor.
*77608$iPrint version:$tLiquid biopsies in solid tumors.$dCham, Switzerland : Humana Press, 2017$z3319509551$z9783319509556$wIMP(OCoLC)(OCoLC)962895674
*830 0$aCancer drug discovery and development.
*85640$uhttp://link.springer.com/10.1007/978-3-319-50956-3
*938  $aEBSCOhost$bEBSC$n1491975
*938  $aYBP Library Services$bYANK$n13884060
*994  $a92$bSESKS
^
Det finns inga omdömen till denna titeln.
Klicka här för att vara den första som skriver ett omdöme.
Vis
Sänd till